Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009. https://doi.org/10.1002/14651858.CD002209.pub2.

Article  PubMed  PubMed Central  Google Scholar 

Ducharme LJ, Abraham AJ. State policy influence on the early diffusion of buprenorphine in community treatment programs. Subst Abuse Treat Prev Policy. 2008;3(1):17.

PubMed  PubMed Central  Article  Google Scholar 

Domínguez-Salas S, Díaz-Batanero C, Lozano-Rojas OM, Verdejo-García A. Impact of general cognition and executive function deficits on addiction treatment outcomes: systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 2016;71:772–801.

PubMed  Article  Google Scholar 

Passetti F, Clark L, Mehta MA, Joyce E, King M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008;94(1–3):82–91.

CAS  PubMed  Article  Google Scholar 

Arias F, Arnsten JH, Cunningham CO, Coulehan K, Batchelder A, Brisbane M, et al. Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults. Addict Behav. 2016;60:137–43.

PubMed  PubMed Central  Article  Google Scholar 

Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36(9):2056–68.

CAS  PubMed  Article  Google Scholar 

Ersche KD, Sahakian BJ. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev. 2007;17(3):317–36.

PubMed  PubMed Central  Article  Google Scholar 

Fernández-Serrano MJ, Pérez-García M, Verdejo-García A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev. 2011;35(3):377–406.

PubMed  Article  CAS  Google Scholar 

Gruber SA, Silveri MM, Yurgelun-Todd DA. Neuropsychological consequences of opiate use. Neuropsychol Rev. 2007;17(3):299–315.

PubMed  Article  Google Scholar 

Lee TMC, Pau CWH. Impulse control differences between abstinent heroin users and matched controls. Brain Inj. 2002;16(10):885–9.

PubMed  Article  Google Scholar 

Verdejo-Garcia A, Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology. 2007;190(4):517–30.

CAS  PubMed  Article  Google Scholar 

Sanborn V, Gunstad J, Shrestha R, Mistler CB, Copenhaver MM. Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment. Appl Neuropsychol Adult. 2020. https://doi.org/10.1080/23279095.2020.1769099.

Article  PubMed  Google Scholar 

Saroj R, Ghosh A, Subodh BN, Nehra R, Mahintamani T, Rana D, et al. Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: a comparative study with three matched control groups. Asian J Psychiatr. 2020. https://doi.org/10.1016/j.ajp.2020.102181.

Article  PubMed  Google Scholar 

Mintzer MZ, Correia CJ, Strain EC. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend. 2004;74(2):205–9.

CAS  PubMed  Article  Google Scholar 

Betts KS, Chan G, McIlwraith F, Dietze P, Whittaker E, Burns L, et al. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies. Addiction. 2016;111(7):1214–23.

PubMed  Article  Google Scholar 

Havard A, Teesson M, Darke S, Ross J. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat. 2006;30(4):355–62.

PubMed  Article  Google Scholar 

Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39(3):520–31.

PubMed  Article  Google Scholar 

Agrawal A, Lynskey MT, Madden PAF, Bucholz KK, Heath AC. A latent class analysis of illicit drug abuse/dependence: results from the national epidemiological survey on alcohol and related conditions. Addiction. 2006;102(1):94–104.

Article  Google Scholar 

Krausz M, Degkwitz P, Kühne A, Verthein U. Comorbidity of opiate dependence and mental disorders. Addict Behav. 1998;23(6):767–83.

CAS  PubMed  Article  Google Scholar 

Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, et al. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2014;40(2):157–62.

PubMed  Article  Google Scholar 

O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700-10 states, July–December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–202.

PubMed  PubMed Central  Article  Google Scholar 

Loeber S, Nakovics H, Kniest A, Kiefer F, Mann K, Croissant B. Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend. 2012;120(1–3):81–7.

PubMed  Article  Google Scholar 

Wilkinson GS. Wide range achievement test 3—administration manual. Wilimington: Jastak Associates Inc; 1993.

Google Scholar 

Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. Washington: American Chemical Society; 2006.

Google Scholar 

Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess. 1996;8(2):145–53.

Article  Google Scholar 

Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test–revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12(1):43–55.

Article  Google Scholar 

Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RK. The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol. 2003;25(4):571–85.

PubMed  Article  Google Scholar 

Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz: Psychological Assessment Resources; 2004.

Google Scholar 

Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test-64 card version professional manual. Odessa: Psychological Assessment Resources; 2000.

Google Scholar 

Wechsler D. Advanced clinical solutions for the WAIS-IV and WMS-IV. San Antonio: Pearson; 2008.

Google Scholar 

Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759–78.

PubMed  Article  Google Scholar 

Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio: Psychological Corporation; 1996.

Google Scholar 

World Health Organization. CIDI-Auto Version 2.1: administrator’s guide and reference. Sydney: Training and reference centre for WHO CIDI; 1997.

Google Scholar 

McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199–213.

CAS  PubMed  Article  Google Scholar 

SPSS. IBM SPSS Statistics Version 21. Boston: Mass Int Bus Mach Corp; 2012.

Google Scholar 

Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48(2):135–41.

CAS  PubMed  Article  Google Scholar 

Eisch AJ, Harburg GC. Opiates, psychostimulants, and adult hippocampal neurogenesis: insights for addiction and stem cell biology. Hippocampus. 2006;16(3):271–86.

CAS  PubMed  Article  Google Scholar 

Lyoo IK, Pollack MH, Silveri MM, Kyung HA, Diaz CI, Hwang J, et al. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology. 2006;184(2):139–44.

CAS  PubMed  Article  Google Scholar 

Byrd DA, Robinson-Papp J, Mindt MR, Mintz L, Elliott K, Lighty Q, et al. Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. J Int Neuropsychol Soc. 2013. https://doi.org/10.1017/S1355617712001634.

Article  PubMed  PubMed Central  Google Scholar 

Gruber SA, Sagar KA, Dahlgren MK, Racine MT, Smith RT, Lukas SE. Splendor in the grass? A pilot study assessing the impact of medical marijuana on executive function. Front Pharmacol. 2016;7:355.

PubMed  PubMed Central  Article  Google Scholar 

Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011;5(1):1.

PubMed  PubMed Central  Article  Google Scholar 

Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, et al. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006;14(2):157–64.

CAS  PubMed  Article  Google Scholar 

Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol. 2007;7:5.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep. 2015;64(26):1–7.

Google Scholar 

Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 2004–2014. Rockville: National admissions to substance abuse treatment s